06 — Commercial Supply Company
Pharmaceutical Commercial Supply Company.
OutcomePartners receive finished product from a site chosen for their dosage form, market and volume.
- Partnership models
- 5
- Partnership models
- Products in the 2026 portfolio
- 43V-20
- Products in the 2026 portfolio
- Markets served
- US · EU · RoW
- Markets served
01
How supply works
Each programme is planned around its budget, timeline and market, with resource and regulatory expertise managed centrally. API development, formulation development, regulatory registration and marketing-authorisation support sit alongside supply rather than in separate contracts.
02
Manufacturing networkV-14
Partners draw on a network of manufacturing facilities with different specialised capabilities, so each product is placed where its dosage form and volume are best served.
03
Partnership models
Five ways to engage, from a single dossier to long-term supply.
- Dossier development
- Dossier compilation
- Co-development with profit sharing
- Technology transfer
- Commercial supply
04
Markets
Generic and differentiated products for the United States, Europe and rest-of-world markets.
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · ganesan@kmshc.com · +91 97898 75194V-23